Clinical Features of Cryptococcal Meningoencephalitis in HIV-Positive and -Negative Patients in a Resource-Limited Setting
- PMID: 37754977
- PMCID: PMC10532421
- DOI: 10.3390/jof9090869
Clinical Features of Cryptococcal Meningoencephalitis in HIV-Positive and -Negative Patients in a Resource-Limited Setting
Abstract
Cryptococcal meningoencephalitis is a systemic fungal infection in immunocompromised and immunocompetent individuals. This study investigated the clinical characteristics and factors associated with mortality in HIV-associated and non-HIV-associated cryptococcal meningoencephalitis in a resource-limited setting. This was a retrospective cohort study of patients with cryptococcal meningoencephalitis between January 2009 and December 2019 at a tertiary teaching hospital in Thailand. Overall, 1019 patients with cryptococcal meningoencephalitis were enrolled, and 923 (90.6%) were HIV-positive. The patients with HIV-associated cryptococcal meningoencephalitis were younger than the HIV-negative patients (37 versus 56 years, p < 0.01). The HIV-negative patients were more likely to have underlying conditions (52.1% versus 7.5%; p < 0.01), had a longer median duration of headaches prior to admission (14 days versus 6 days, p < 0.01), and were more likely to have an altered mental status at presentation (36.5% versus 18.6%, p < 0.01) and pulmonary involvement (15.6% versus 0.8%, p < 0.01). The HIV-positive patients had lower cerebrospinal fluid (CSF) white blood cell counts (4 versus 94 cells/mm3; p < 0.01), lower CSF protein (69 versus 157 mg/dL; p < 0.01), higher CSF glucose (38.8 versus 21 mg/dL; p < 0.01), and more frequent cryptococcemia (44.1% versus 20.5%; p < 0.01). The mortality rate was high but not significantly different between the two groups (30.2% versus 33.2%; p = 0.53). The HIV-positive patients with comorbidities, fever, an altered mental status at presentation, a CSF white blood cell count below 20 cell/mm3, fungemia, and positive CSF India ink were independently associated with 30-day mortality. In comparison, an altered mental status at presentation and fungemia were associated with 30-day mortality in HIV-negative patients. In conclusion, HIV-negative patients with cryptococcal meningoencephalitis had more extensive central nervous system inflammation, although the two groups' mortality rates were similar. Unfavorable prognostic factors included comorbidities, fever, an altered mental status at presentation, a low CSF white blood cell count, fungemia, and positive CSF India ink.
Keywords: Cryptococcus; HIV; cryptococcal meningitis; cryptococcal meningoencephalitis; cryptococcosis; fungal infection.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Cryptococcal meningoencephalitis and pneumonia in a HIV positive patient: A case report.Clin Case Rep. 2024 Jul 23;12(8):e9196. doi: 10.1002/ccr3.9196. eCollection 2024 Aug. Clin Case Rep. 2024. PMID: 39055090 Free PMC article.
-
Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection.J Microbiol Immunol Infect. 2011 Oct;44(5):338-45. doi: 10.1016/j.jmii.2010.08.011. Epub 2011 Jan 20. J Microbiol Immunol Infect. 2011. PMID: 21524972
-
Increased cryptococcal meningitis mortality among HIV negative, non-transplant patients: a single US center cohort study.Ther Adv Infect Dis. 2020 Jul 8;7:2049936120940881. doi: 10.1177/2049936120940881. eCollection 2020 Jan-Dec. Ther Adv Infect Dis. 2020. PMID: 32685148 Free PMC article.
-
Cryptococcal Immune Reconstitution Inflammatory Syndrome: From Clinical Studies to Animal Experiments.Microorganisms. 2022 Dec 7;10(12):2419. doi: 10.3390/microorganisms10122419. Microorganisms. 2022. PMID: 36557672 Free PMC article. Review.
-
Cryptococcal Meningoencephalitis in Phenotypically Normal Patients.Pathogens. 2023 Oct 31;12(11):1303. doi: 10.3390/pathogens12111303. Pathogens. 2023. PMID: 38003768 Free PMC article. Review.
Cited by
-
Cryptococcal meningoencephalitis and pneumonia in a HIV positive patient: A case report.Clin Case Rep. 2024 Jul 23;12(8):e9196. doi: 10.1002/ccr3.9196. eCollection 2024 Aug. Clin Case Rep. 2024. PMID: 39055090 Free PMC article.
-
The emerging links between immunosenescence in innate immune system and neurocryptococcosis.Front Immunol. 2024 Aug 20;15:1410090. doi: 10.3389/fimmu.2024.1410090. eCollection 2024. Front Immunol. 2024. PMID: 39229268 Free PMC article. Review.
-
Pulmonary cryptococcosis with headache as the first presentation: A case report.Open Life Sci. 2025 Aug 12;20(1):20251119. doi: 10.1515/biol-2025-1119. eCollection 2025. Open Life Sci. 2025. PMID: 40822967 Free PMC article.
References
-
- Pappas P.G., Perfect J.R., Cloud G.A., Larsen R.A., Pankey G.A., Lancaster D.J., Henderson H., Kauffman C.A., Haas D.W., Saccente M., et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin. Infect. Dis. 2001;33:690–699. doi: 10.1086/322597. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources